YE, Binglin. CRISPR-dCas9 in Cancer Epigenetic Therapy Progress. MedScien, [S. l.], v. 3, n. 4, p. 4202, 2025. DOI: 10.61173/d53knt23. Disponível em: https://ms.deanfrancis.press/article/view/825. Acesso em: 4 nov. 2026.